2026 - 06 - 22 | Roundtable Launches Real - Time, AI / DeFi Payment Platform | NDAQ: RTB

Roundtable (NASDAQ: RTB) said it launched real-time onchain ad-payment infrastructure for professional publishers, enabling nearly 200 publishers to receive USDC as soon as ad revenue is earned. Coinbase will provide wallet support and USDC payment rails via Coinbase Prime. The company says its Media Liquidity Pool and smart-wallet network settle transactions instantly and record them on-chain.

Original reporting
Published Jun 22, 2026, 6:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 22, 2026, 7:16 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefTechnology
Primary signal
$RTB
Bullish
medium confidence
Mentioned
$RTB
Relevance
7/10
AlphAI data visualization · based on stockhouse.com
Decision brief

The 30-second read

$RTBBullishMed
01

Why it matters

The immediate trading relevance is whether this product launch meaningfully increases publisher engagement and monetization efficiency; without KPIs, the market may treat it as an early-stage adoption signal.

02

Market read

A concrete product launch (real-time USDC settlement) with an initial publisher rollout (nearly 200) can shift expectations for RTB’s platform traction, but lacks financial quantification.

03

What to watch

Key unknowns include whether publishers actually increase ad spend/retention due to faster settlement, the cost/risks of maintaining the liquidity pool, and any regulatory/operational friction in onchain payment rails.

Relevance 7/10Novelty 6/10Timing: Beginning this week (immediate rollout)

Background

RTB positions itself as an AI/DeFi enterprise media platform; this release focuses on real-time onchain payment infrastructure for professional media ad settlement.

Company-level read

Ticker impact

$RTBBullishMedium confidence
Context

Roundtable (RTB) launched real-time onchain ad settlement infrastructure, enabling nearly 200 publishers to receive USDC immediately.

Expected impact

Near-term sentiment tailwind; magnitude depends on whether the launch converts into measurable bookings/ARPU in upcoming updates.

Evidence & confidence

The article is a product/infra launch with concrete rollout scope (nearly 200 publishers) and a named settlement rail (USDC via Coinbase), but it provides no financial metrics or guidance to quantify impact.

Market effects

Highlights a potential shift in ad-tech settlement from TradFi cycles toward tokenized/instant rails, which could pressure incumbents’ settlement timelines.

Limited direct regional read-through; messaging is global (Cannes/USDC rails).

USDC/Coinbase rails are broadly accessible, so adoption could be cross-border if publishers integrate.

Counterpoint

The launch may be largely promotional until RTB reports conversion metrics (publisher activity, transaction volume, take-rate) and confirms sustainability of the USDC liquidity pool economics.

Key entities

  • RTB Digital, Inc. (Roundtable)

    Announced real-time onchain payment infrastructure for professional media ad settlement using USDC.

  • Coinbase

    Provides USDC wallet support and payment rails via Coinbase Prime/Coinbase Institutional.

  • USDC

    Settlement asset used for instant ad revenue payments on-chain.

Related articles

$RTBHighAI 9/10

RTB Digital, Inc.: Roundtable Secures 10-Year, $1 Billion Agreement, Bringing its AI/DeFi Media Operating System to Global Scale and Profitability

Roundtable (RTB) announced a 10-year, $1 billion deal with Paradium.AI (PAAI) to migrate PAAI's media portfolio onto RTB's AI/DeFi MediaOS. RTB expects $100 million annual revenue and EBITDA positivity, with 100 million monthly consumers. The partnership aims to reduce costs, increase profits, and provide global scale for media brands.

$BDTXHighAI 9/10

Raymond James reiterates Black Diamond stock rating on trial data

Raymond James reiterated an Outperform rating and $11 price target for Black Diamond Therapeutics (BDTX), citing positive Phase 2 trial data for silevertinib in non-small cell lung cancer. The stock is near its 52-week low of $1.60. The FDA has provided feedback on the Phase 3 trial design, and the company reported Q3 2026 earnings. Stifel raised its price target to $14, maintaining a Buy rating.

$NVDAMed

Goldman Sachs Says Chip Selloff Went Too Far, Flags Nvidia, Broadcom and AMD as Buys

Goldman Sachs believes the semiconductor selloff has been excessive, highlighting Nvidia (NVDA), Broadcom (AVGO), and AMD (AMD) as attractive investment opportunities. The firm notes that these stocks are now in oversold territory, with compelling valuations even under pessimistic scenarios. The call comes after a significant market downturn, with the Philadelphia Semiconductor Index down 21% over the past month.

$REGNMedAI 8/10

Regeneron Pharmaceuticals Advances Liver Drug After Early Trial Cuts Liver Fat by Up to 80%

Regeneron Pharmaceuticals reported that its liver drug candidate reduced liver fat by up to 80% in early trials. The company cautioned that further studies are needed to confirm clinical benefits. Regeneron is exploring non-invasive measures for liver disease assessment and has identified genetic factors linked to lower liver disease risk. The company estimates the U.S. MASH market at $1 billion, potentially growing to $15 billion by 2035.